Latest Breaking News On - Director jeffrey riley - Page 1 : comparemela.com

Gain Therapeutics Inc (NASDAQ:GANX), a company specializing in the development of novel therapeutics to treat central nervous system and lysosomal storage diseases, has seen a notable insider transaction.

Jeffrey rileyGain therapeutics incGurufocus valueSignificantly overvaluedDirector jeffrey riley